Skip to main content

Table 1 Measurements implemented in WP I

From: Study protocol: evaluation of the addictive potential of e-cigarettes (EVAPE): neurobiological, sociological, and epidemiological perspectives

Initial information

Sociodemographic data

 

Structured Clinical Interview for DSM-5 [SCID-I; 77]

 

Preexisting conditions and medication

 

MRI suitability

 

Drug screening

 

Pregnancy test (for women)

Nicotine consumption

CO-measurement

 

Saliva sample (cotinine)

 

E-cigarette use (device, liquid, consumption pattern)

 

Smoking and vaping history

 

Form 90 interview for smoking and vaping [adapted from 78]

 

Fagerström Test of Cigarette Dependence [FTCD; 79]

 

Penn State Electronic Cigarette Dependence Index [PS-ECDI; 17]

 

Craving-Automatized-Scale for Cigarette Smoking [CAS-CS; 80]

 

Craving-Automatized-Scale for Vaping [CAS-V; 80]

 

Questionnaire of Smoking Urges [QSU; 81]

 

Questionnaire of Vaping Craving [QVC; 82]

 

Smoking Consequences Questionnaire [BSCQ-A; 83]

 

Vaping Consequences Questionnaire [VCQ; adapted from 82]

 

Minnesota Tobacco Withdrawal Scale [MTWS-R; 84]

Emotional state

Perceived Stress Scale [PSS; 85]

 

Positive And Negative Affect Schedule [PANAS; 86]

 

Barratt-Impulsiveness-Scale [BIS-11; 87]

Neuropsychological assessment

Implicit Association Task [88]

 

Kirby Delay Discounting Task [89]

 

Iowa Gambling Task [90]

fMRI examination

Resting-state

 

MOTTA-task [57]

 

Cue-reactivity task [74]

 

Visual dot-probe-task combined with eye-tracking [69]

 

MPRAGE